Intercure Ltd. (INCR)

NASDAQ: INCR · IEX Real-Time Price · USD
6.00
0.30 (5.26%)
At close: Jan 25, 2022 4:00 PM
5.86
-0.14 (-2.33%)
After-hours:Jan 25, 2022 4:00 PM EST
Market Cap273.68M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out45.61M
EPS (ttm)n/a
PE Ration/a
Forward PE16.78
Dividendn/a
Ex-Dividend Daten/a
Volume10,730
Open5.76
Previous Close5.70
Day's Range5.75 - 6.00
52-Week Range1.43 - 9.99
Beta-0.62
AnalystsStrong Buy
Price Targetn/a
Earnings Daten/a

About INCR

InterCure Ltd, together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

IndustryDrug Manufacturers-Specialty & Generic
Founded1994
Employees75
Stock ExchangeNASDAQ
Ticker SymbolINCR
Full Company Profile

Financial Performance

Financial numbers in millions NISFinancial Statements

News

Berner's Cookies Enters Europe Via Partnership With InterCure, Will Open Stores In Austria & U.K.

Cannabis brand Cookies announced Thursday its international expansion into Europe through a partnership with Israel-based marijuana company InterCure (NASDAQ:INCR). The parties signed a multi-year deal ...

1 month ago - Benzinga

InterCure Announces European Expansion with International Cannabis Brand Cookies

Leading Global Cannabis Company InterCure Partners with Cookies to Open Retail Locations in Austria and the U.K. in Early 2022 Leading Global Cannabis Company InterCure Partners with Cookies to Open Ret...

1 month ago - GlobeNewsWire

International Cannabis Brand Cookies and InterCure Announce European Expansion

SAN FRANCISCO--(BUSINESS WIRE)--Iconic cannabis brand Cookies today announced its international expansion into Europe through a partnership with Israel-based InterCure (NASDAQ: INCR), the leading, profi...

1 month ago - Business Wire

InterCure to Participate in Cowen's 4th Annual Cannabis Conference

Mr. Rabinovitch to participate in the ‘International' panel at 11:50 a.m. ET on Tuesday, November 30, 2021 Mr. Rabinovitch to participate in the ‘International' panel at 11:50 a.m. ET on Tuesday, Novemb...

1 month ago - GlobeNewsWire

Israeli Cannabis Co. Intercure Posts Record Q3 Revenue Of CA$25M, Dispenses One Ton Of GMP Medical Cannabis In Oct.

Israeli cannabis company InterCure Ltd. (NASDAQ:INCR) (TSX:INCR) (TASE: INCR), which does business as Canndoc, released its third-quarter financial results Monday revealing all-time record quarterly rev...

2 months ago - Benzinga

InterCure Announces Record Third Quarter Financial Results with 3 Times YoY Revenue Growth and 36% QoQ Growth

Seventh consecutive quarter of high double-digit, sequential revenue growth

2 months ago - GlobeNewsWire

InterCure Expands Pharmacy Chain in Israel; Surpasses One-Ton Medical Cannabis Products Dispensed Per Month

With addition of four new pharmacies , InterCure 's dedicated chain GIVOL now has 20 locations across Israel

2 months ago - GlobeNewsWire

Israeli Cannabis Co. InterCure's Shares Up On Preliminary Q3 Record Revenue Of $19.41M

InterCure Ltd. (NASDAQ: INCR) (TSX:INCR) (TASE: INCR), doing business as Canndoc,  r eported Monday  preliminary unaudited revenue of CA$24 million ($19.41 million)  for the third quarter of 2021.

3 months ago - Benzinga

InterCure Announces Record Preliminary Third Quarter Revenue of CAD$24 million - 3 Times YOY and 36% QOQ Growth

Achieved a number of firsts and records including:

3 months ago - GlobeNewsWire

InterCure CEO Alex Rabinovitch Purchases Over 420,000 Shares of Company Stock in The Open Market

NEW YORK, TORONTO and HERZLIYA, Israel, Oct. 12, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that CEO A...

3 months ago - GlobeNewsWire

InterCure to Webcast Live at VirtualInvestorConferences.com September 9th

NEW YORK and TORONTO and HERZLIYA, Israel, Sept. 8, 2021 /PRNewswire/ -- InterCure Ltd.

4 months ago - PRNewsWire

InterCure Re-Announces its Record-Breaking Second Quarter Financial Results With 4 Times YOY Revenue Growth - Followi...

Achieved record revenue of NIS 45 million (over CAD$17 million), an increase of 400% year-over-year and 37% quarter-over-quarter

4 months ago - GlobeNewsWire

InterCure To Buy Strategic Assets From Cannomed On Heels Of Its NASDAQ Debut

InterCure Ltd. (NASDAQ:INCR) (TSX:INCR) (TASE: INCR) revealed on Thursday that it will buy strategic assets from Cannomed (TASE: CNMD), an Israel-based company and owner of a pharmacy chain specializing...

4 months ago - Benzinga

Israeli Cannabis Co. InterCure Begins Trading On NASDAQ, Chaired By Former Prime Minister

One of Israel's largest cannabis companies, InterCure Ltd. (NASDAQ:INCR) began trading on the NASDAQ Global Market on Wednesday.

4 months ago - Benzinga

InterCure Continuing its Medical Cannabis Consolidation Strategy, Announces Strategic Acquisition of Cannomed Pharmac...

Acquisition includes two medical cannabis dispensing pharmaci es , another pharmacy in the process of receiving its license and a medical cannabis patient support center

4 months ago - GlobeNewsWire

InterCure Commences Trading on NASDAQ Under the Symbol “INCR”

The leading cannabis company outside North America debuts today on Nasdaq The leading cannabis company outside North America debuts today on Nasdaq

4 months ago - GlobeNewsWire